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CLINICAL CASE SEMINAR
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A 40-yr-old female presented with an extensive lesion of the
sellar area and the sphenoid sinus, spreading to the optic
nerves and associated with pachymeningitis. Histological
findings were consistent with an inflammatory pseudotumor,
and steroid treatment allowed the disappearance of all the
lesions.
Inflammatory pseudotumors of the pituitary are very rare.
This case appears unique with regard to the extension of the
lesions and the dramatic response to medical treatment. The
differential diagnosis of inflammatory lesions of the pituitary
is difficult. It relies mainly on histological analysis and in-
cludes sarcoidosis, Wegener’s granulomatosis, histiocytosis
(Langerhans, Rosai-Dorfman, and Erdheim-Chester diseases)
and lymphocytic hypophysitis. (J Clin Endocrinol Metab 86:
4603–4610, 2001)
DESPITE THE ACCURACY of current diagnostic tools,nonadenomatous lesions of the pituitary still create
diagnostic challenges to the endocrinologist. The most fre-
quent lesions that may be encountered are Wegener’s gran-
ulomatosis, Langerhans histiocytosis, sarcoidosis, lympho-
cytic and granulomatous hypophysitis, and bacterial and
parasitic infections. These may be of autoimmune origin and
may represent the first manifestation of a systemic disease.
Their precise identification is crucial to determine the most
appropriate treatment, which is usually nonaggressive med-
ical therapy.
We present the case of an extensive inflammatory pituitary
lesion, spreading to the sphenoid sinus, meninges, and fron-
tal lobes. In the light of clinical and laboratory results, the
diagnosis of inflammatory pseudotumor (Ip) was made. Cor-
ticosteroid treatment caused marked clinical, biochemical,
and imaging improvement. The case in this report is unique
with regard to extension of the lesion and its response to
therapy.
Case Report
A 40-yr-old African woman presented several times with
frontal headaches at the out-patient clinic between April and
December 1996. The clinical and laboratory findings, elec-
troencephalogram, and computed tomography scan of the
brain were normal. In December 1996, the intensity of the
headaches increased, and she complained of rapidly losing
sight in her left eye. The patient also complained of lack of
menses for 3 months and severe asthenia for 2 wk. Her
previous history included pulmonary tuberculosis in 1993
and the delivery of a healthy baby in 1995.
Clinical examination revealed mild fever, left exophthal-
mos, and amaurosis. Brain magnetic resonance imaging
(MRI; Fig. 1, A and B) showed that the sphenoid sinus was
filled with T2 hyperintense material. Contrast enhancement
demonstrated that the lesion involved the pituitary, the area
of the optic chiasma, and nerves, mainly on the left side.
Pachymeningitis was observed in front of the sphenoidal
jugum, at the level of the cranial base dura and of the
falx cerebri. Examination of the cerebrospinal fluid (CSF)
revealed a moderately increased protein concentration
(636 mg/liter; normal, 150–450), normal glycorrhachia and
chlorine levels, and abnormal cell count (no red cells and 62
white cells/mm3; mainly lymphocytes). Laboratory tests
showed a normal white blood cell count, an increased eryth-
rocyte sedimentation rate (85 mm/h; upper limit, 10), and
increased C-reactive protein (12 mg/liter; upper limit, 6).
Taking into account her past medical history, the diagnosis
of a central nervous system tuberculosis was considered first,
but the CSF abnormalities were not in favor of mycobacterial
infection. Iv antibacterial and antifungal treatment was
started. CSF, sputum, urine, and gastric fluid cultures were
all negative for bacteria, fungi, and parasites, including acid
test bacilli. The PCR for Mycobacterium tuberculosis performed
on gastric fluid was also negative. Chest x-ray was normal.
These results did not support the diagnosis of an infection,
including mycobacterial meningoencephalitis.
Complementary biological evaluation
Protein electrophoresis was normal. Carcinoembryonic
antigen and human immunodeficiency virus antibodies in
the blood were negative. Immunological tests (rheumatoid
factor, antinuclear antibodies, C3 and C4 levels, antineutro-
Abbreviations: CSF, Cerebrospinal fluid; Ip, inflammatory pseudo-
tumor; Lh, lymphocytic hypophysitis; MRI, magnetic resonance
imaging.
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phil antibodies, angiotensin-converting enzyme) were nor-
mal. Endocrinological tests revealed pituitary insufficiency
with low gonadotropins levels [LH, 2.4 IU/liter (normal,
1–20); FSH, 2.9 IU/liter (normal, 2–17.4)] and low E2 levels
(12 ng/liter; normal, 30–200). TSH was not elevated (0.69
mIU/liter; normal, 0.2–5.2) in the presence of a decreased
free T3 (1 ng/liter; normal, 1.5–3.1) and free T4 (3.8 ng/liter;
normal, 7–17) concentrations. Blood PRL levels were in-
creased (104g/liter; normal, 2.2–24), and basal GH was low
(0.06 g/liter). Low T3 and T4 and normal basal TSH were
in favor of secondary hypothyroidism. This was confirmed
by the TRH test, which showed no TSH response (maximum
value, 2.5 mIU/liter after 30 min). Evaluation of adrenocor-
tical function provided inconclusive results.
Clinical course
Treatment with oral l-T4 and cortisone markedly im-
proved the asthenia. As the lesion displayed inflammatory
features at MRI, in January we started corticosteroid treat-
ment (250 mg methylprednisolone, iv, on d 1 and 2 and 125
mg, iv, on d 3 and 4). Two weeks later, the patient improved
her general condition, the exophthalmos and fever disap-
peared, the headaches decreased in intensity, left visual acu-
ity improved, and periodic menses reappeared. Laboratory
tests also improved (erythrocyte sedimentation rate, 29
mm/h; PRL, 29 g/liter). CSF biochemistry and cell count
were normalized, and MRI showed a shrinkage of the sellar
mass. MRI with gadolinium enhancement revealed that the
lesion persisted in the pituitary, left optic nerve, and frontal
meninges. The dramatic response to corticosteroids sug-
gested an inflammatory process and led to a transsphenoidal
biopsy of the lesion.
Histological examination
Biopsies were fixed in 10% buffered formalin and stained
with hematoxylin and eosin, periodic acid-Schiff reaction,
and Zhiehl-Neelsen stain to exclude fungi and tubercular
bacilli infection, respectively. Paraffin-embedded sections
were dewaxed in xylene, rehydrated through a graded series
of decreased concentrations of ethanol, heated in a micro-
wave oven in citrate buffer (0.1 mol/liter; pH 6.0) for antigen
retrieval, and incubated for 2 h with several primary
antibodies.
The immunohistochemical study relied on the avidin-
biotin-peroxidase complex method (ABC, Vector Labora-
tories, Inc., Foster City, CA), using monoclonal antibodies,
including those for vimentin (DAKO Corp., Glostrup,
Denmark; 1:800 dilution), desmin (DAKO Corp.; 1:200),
actin (muscle; DAKO Corp.; 1:400), CD68 (DAKO Corp.;
1:200), CD1a (Novocastra, Newcastle, UK; 1:20), and S100
(DAKO Corp.; 1:1,000), and polyclonal antibodies for 
and  Igs chains (DAKO Corp.; 1:40,000). After rinsing, the
endogenous peroxidase was blocked with 1% hydrogen
peroxide. Parallel sections were incubated with irrelevant
normal mouse or rabbit serum as a negative control.
Two main elements could be identified: spindle-shaped
cells mixed with collagen deposits and clusters of inflam-
matory cells (mainly lymphocytes and plasma cells mixed
with some neutrophils; Fig. 2). Inflammatory cells were pre-
dominant superficially, whereas fibrous areas and bone de-
struction were observed in depth (Figs. 3 and 4, A–C). Few
blood vessels were identified in the center of the lesion. The
peripheral area was not clearly delimited, and sinus epithe-
lium presented with ulcerative lesions. Neither granulomas
nor necrosis were seen. Reactions using periodic acid-Schiff
and Zhiehl-Neelsen stains were negative.
Immunohistochemichal examination revealed an inten-
sive positive cytoplasmic reaction of plasma cells for  (Fig.
FIG. 1. A and B, Coronal (A) and sagittal (B) gadolinium-enhanced T1
spin-echo MRI. Demonstration of a heterogeneous lesion involving
the sphenoid sinus with extension into the sellar area. Enlargement
of the left optic nerve is present.
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5A) and  (Fig. 5B) light chains. Among fibrous areas, spin-
dle-shaped cells were strongly positive for antivimentin (Fig.
6A) and antiactin (Fig. 6B) and weakly positive for anti-
desmin (Fig. 7), whereas S100 protein (Fig. 8A) and CD1a
(Fig. 8B) were negative.
The presence of TNF was also assessed (1). Immunohis-
tological techniques used New Gushine (red coloring). Ep-
ithelium as well as some of the stromal cells were stained in
red (Fig. 9, A and B). Some of these appeared to be typical
plasma cells (Fig. 9C).
Diagnosis
Frequent pituitary pathologies, such as adenomas and
craniopharyngiomas, were easily ruled out on the basis of
histological characteristics of the excised material. The
inflammatory origin of the lesion was likely, but its further
identification proved difficult. Its differential diagnosis
shall be considered in the discussion. Taking into account
the histological features, the marked response to cortico-
steroid treatment and the lack of evidence for any auto-
immune disease, the diagnosis of an Ip involving the sphe-
noid sinus, sellar area, optic chiasma, optic nerves, and
meninges was made.
Clinical course
Treatment with oral corticosteroids was started and was
maintained for 10 months. Six months after the end of treat-
FIG. 2. Bone with plasma cell infiltration and fibroblastic prolifera-
tion (hematoxylin-eosin stain; magnification, 100).
FIG. 3. Sinus mucosa: numerous plasma cells and edema are seen
within the stroma (hematoxylin-eosin stain; magnification, 100).
FIG. 4. A, Two aspects of the lesion: on the right, fibromyxoid area
with spindle-shaped fibroblasts and inflammatory cells; on the left,
clusters of lymphocytes, numerous plasma cells and residual bone
fragments (dark; hematoxylin-eosin stain; 100). B, High magnifi-
cation of A: collagen deposits, plasma cells, and clusters of lympho-
cytes (hematoxylin-eosin stain; magnification, 400). C, High mag-
nification of A: numerous plasma cells and fibrous tissue with
fibroblasts (hematoxylin-eosin stain; magnification, 400).
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ment, the patient remained free of clinical symptoms. Con-
trol MRI was normal (Fig. 10, A and B), and substitutive
thyroid treatment could be discontinued. T3, T4, PRL, and
dehydroepiandrosterone sulfate levels were normal. A TRH
test showed a normal basal TSH (1.6 mIU/liter) with a nor-
mal increase in serum TSH concentrations (peak, 7.8 mIU/
liter after 15 min). Eight months after the end of treatment,
the patient presented with epilepsy. Brain MRI showed bi-
lateral isolated frontal pachymeningitis. CSF showed the
presence of inflammatory cells, and the erythrocyte sedi-
mentation rate was increased. Corticosteroids were intro-
duced for 2 months, and azathioprine (100 mg Imuran/d;
Glaxo Wellcome Inc., Temple Hill, UK) was given as a long-
term treatment. Control MRI showed no abnormalities.
Seven months after the withdrawal of corticosteroids, the
patient became psychotic. Brain MRI demonstrated bilateral
frontal pachymeningitis with extensive bilateral frontal lobe
edema (Fig. 11). This second relapse was treated with a new
course of corticosteroids and oral methotrexate (7.5 mg/wk).
Azathioprine medication was replaced by oral methotrexate
(7.5 mg/wk). Once again, corticosteroids produced a complete
disappearance of the lesions after 4 wk (Fig. 12). Eighteen
months later, the patient reported no specific complaints.
Discussion
Nonadenomatous lesions of the pituitary consist of a het-
erogeneous group of infectious, neoplastic, and immunolog-
ical diseases (2). Sophisticated diagnostic procedures are of-
ten necessary to provide an accurate diagnosis, which, in the
case of infectious or inflammatory etiology, may lead to a
nonaggressive and efficient medical therapy. In our case the
clinical and laboratory findings were not specific enough to
allow a definite diagnosis. MRI only ruled out a possible
pituitary adenoma. Considering the past medical history of
the patient, central nervous system tuberculosis appeared to
be a putative diagnosis (3), but additional tests excluded this
possibility. Primary or metastatic tumors of nonpituitary
origin were unlikely according to the lack of neoplastic cells
in the biopsy material. Solitary plasmocytoma of the sphe-
noid sinus involving the pituitary fossa (4) has been reported,
but this diagnosis was ruled out because plasma cells were
polyclonal for  and  light chains. Pituitary histiocytosis
were also considered. Langerhans histiocytosis was de-
scribed in the sellar area, but the selective adenohypophyseal
insufficiency and the lack of cells expressing S100 protein or
CD1a caused the rejection of this hypothesis (2).
Rosai-Dorfman disease is a rare histoproliferative disease
affecting the lymph nodes. In approximately 43% of cases,
extranodal sites may be involved (5). Central nervous system
FIG. 5. A and B, Immunohistochemical staining of  (A) and  (B)
light chains shows a cytoplasmic expression on plasma cells (magni-
fication, 250).
FIG. 6. A and B, Immunohistochemistry shows spindle cells overex-
pressing vimentin (A) and actin (B).
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manifestations of the disease are rare and most of the time
are dura-based, resembling meningiomas (6). Yet, one case of
an isolated intraparenchymal cerebral lesion without dural
attachment (6) and another of pituitary tumor (7) have been
reported. Microscopically, the lesion consists of proliferative
histiocytes exhibiting the characteristic cytoplasmic staining
against S100 (5). Although the clinical characteristics of the
lesion observed in our patient could suggest a Rosai-Dorf-
man disease, the histological pattern and especially the lack
of cells expressing S100 made this diagnosis unlikely.
Erdheim-Chester disease is a rare non-Langerhans cells
histiocytosis affecting multiple organ systems (8). Symmetric
sclerosis of the long bones is usually reported, but the central
nervous system (8) and sinus (9) can also be affected. Among
patients with central nervous system involvement, the most
frequent manifestations are diabetes insipidus, cerebellar
syndromes, orbital lesions, and extra-axial masses involving
the dura (8). Histologically, Erdheim-Chester disease is char-
acterized by plasma cell infiltration, mixed with lympho-
cytes, large histiocytes with foamy cytoplasm, and Touton
giant cells. Histiocytes express CD68, occasionally S100, and
never CD1a. This pattern was not observed in our patient.
Sarcoidosis is known to involve the central nervous system
in about 10% of cases. Sellar localization is the most frequent
one and may be complicated by aseptic meningitis and cra-
nial nerve palsies (10). Yet, primary sinus localization is
uncommon, and extensive cerebral lobes edema is not men-
tioned. The normal blood angiotensin-converting enzyme
values were not in favor of this diagnosis. Sarcoidosis may
show similar histological abnormalities in pituitary com-
pared with lymph nodes (11), granulomas (which may be less
delimited in pituitary), concentric fibrosis, and T cell infil-
trate around granulomas. None of these elements was ob-
served in the lesion. For these reasons, the diagnosis of sar-
coidosis was rejected.
Wegener’s granulomatosis was not compatible with the
histological abnormalities cited above, especially as no vas-
culitis was reported. Extensive cerebral lobe edema was also
not suggestive of Wegener’s granulomatosis.
Necrotizing infundibulo-hypophysitis has been described
in two patients (12) presenting with an unusual form of
lymphocytic hypophysitis (Lh), as diabetes insipidus was the
main endocrinological abnormality, and necrosis was highly
present at histological analysis. Our patient did not present
either of these characteristic elements. It should also be
stressed that necrotizing infundibulo-hypophysitis as well as
the usual form of Lh may extend to the hypothalamus or the
chiasmatic area, but never involves the meninges or the ce-
rebral lobes (12, 13).
The histological pattern of the biopsy specimen was not
specific, but the demonstration of polyclonal plasma cells
and lymphocytes surrounded by fibrous tissue rich of myo-
fibroblastic spindle cells allowed us to consider the diagnosis
of an Ip. The latter is mainly one of exclusion, as there are no
pathognomonic features or specific tests to confirm it (14).
This possibility was supported by the fact that the lesion
appeared radiologically extensive and contrast enhancing
(15), and it was remarkably responsive to corticosteroids (16).
The term Ip is not unanimously accepted by all patholo-
gists. However, considering the lack of histological consen-
sus, in this article we shall continue to use it. Ip are rare and
were described for the first time in their orbital localization
(17) and later in lungs (18), upper respiratory tracts (19), head
and neck (14, 15), gastrointestinal (20) and urinary tracts (21),
as well as central nervous system (22). The term Ip represents
inflammatory lesions with a broad spectrum of histological
features, varying from a predominance of inflammatory cells
FIG. 7. Spindle cells weakly express desmin (magnification, 250).
FIG. 8. A and B, Spindle cells do not react with antibodies for S100
(A) or CD1a (B; magnification, 250).
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mixed with some fibrous tissue to extensive fibrous lesions
trapping some inflammatory cells (14). These two main as-
pects are respectively referred to as plasma cell granulomas
and fibrous Ip (14, 15) and can be part of the multiple fibro-
sclerosis syndrome. The latter was described as any associ-
ation of retroperitoneal fibrosis, mediastinal fibrosis, scle-
rosing cholangitis, Riedel’s thyroiditis, and fibrosing
pseudotumor of the orbit (23). A possible association be-
tween these different entities and testicular fibrosis as well as
fibrous proliferation of the sellar and parasellar area (24) was
suggested. Hypertrophic intracranial pachymeningitis was
also considered to be part of the syndrome of multiple fi-
brosclerosis (14, 25).
The etiology of Ip remains obscure. An autoimmune hy-
pothesis is thought to be the most likely, supported by the
association of Ip with type I diabetes mellitus, rheumatoid
arthritis, and systemic lupus erythematosus and by the ther-
apeutic response to immunosuppressive drugs (14).
FIG. 9. A and B, Tissue sample stained (in red) with anti-TNF mono-
clonal antibody (A) or with a nonimmune rabbit IgG (B), revealed with
a alkaline phosphatase-labeled goat antirabbit antibody (magnifica-
tion, 40). C, High magnification of A. Two plasma cells, stained in
red, are indicated by arrows (magnification, 80).
FIG. 10. A and B, Coronal (A) and sagittal (B) gadolinium-enhanced
MRI. Disappearance of the lesions is noted.
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The treatment of Ip is controversial. Many researchers
agree that accessible lesions should be first treated surgically
(14, 19). When surgery cannot be performed or is incomplete,
corticosteroids may be administered, with a greater efficacy
in pure inflammatory lesions than in fibrous lesions (26). In
patients not responding to corticosteroid treatment or when
surgery cannot be performed, radiotherapy can be helpful
(19). Otherwise, immunosuppressive drugs [cyclosporine
(27), methotrexate (28), azathioprine (14), or cyclophospha-
mide (29)] can be used. Despite all of these treatments, a
relapse rate of 37% has been reported (30).
The regression of the lesion and the normalization of the
endocrine tests, observed in our patient after corticosteroid
treatment, do not support the role of pituitary cell destruc-
tion as a cause of pituitary insufficiency. Pituitary cell com-
pression by the inflammatory process may account for pi-
tuitary insufficiency, although the involvement of local
secretion of TNF in its pathogenesis can be hypothesized.
Indeed, it has been demonstrated in rat pituitary cell cultures
that TNF inhibits the hormonal response of the pituitary to
hypothalamic releasing factors (31). We detected large
amounts of this cytokine in the biopsy sample using a mono-
clonal antibody. These amounts were probably underesti-
mated because of previous corticosteroid therapy.
Several cases of Ip of the sinuses have been reported: 11
cases of maxillary tumors (15, 32–36) and 4 sphenoid tumors
(37, 38–40). Only 2 of these patients suffered from pituitary
insufficiency (37, 38). To the best of our knowledge, only 1
case of Ip that associates involvement of the sphenoid sinus
and the sellar area together with pituitary insufficiency and
cranial nerve palsies has been reported (37). However, our
case is unique with regard to the marked extension of the
lesion and the dramatic response to medical treatment. We
found no description in the literature of total disappearance
of the radiological lesions among patients presenting with
pituitary insufficiency even if they received combined cor-
ticosteroid treatment and radiotherapy (37, 38). The 2 pa-
tients presenting with pituitary insufficiency remained de-
pendent on hormonal replacement therapy (37, 38). The
excellent response to corticosteroid treatment observed in our
patient could be due to a limited amount of fibrosis of the lesion.
Lh may be associated with clinical and laboratory fea-
tures similar to those displayed by our patient. Lh appears
radiologically to be an expansive contrast-enhancing le-
sion of the antehypophysis (13) and the endocrinological
abnormalities usually include thyroid, adrenocortical,
and/or gonadal insufficiency associated with mild hyper-
prolactinemia (13). Circulating antibodies to PRL have
been identified in some patients. The histological pattern
is one of a polyclonal lymphoplasmocytic infiltration, in
some cases accompanied by fibrosis. Lh shows a striking
female predilection and commonly affects women during
pregnancy or the puerperium (13).
Taking into account these similarities, the diagnosis of Lh
had to be considered in our case. However, it was ruled out
because the lesion was too extensive. Lh is more localized
and is almost always limited to the sellar area. Some re-
searchers have reported extensions to the posterior lobe or
infundibulum, to the suprasellar area, to the cavernous si-
nuses, or to the carotid arteries (41). However, more exten-
sive lesions have not been described, and Lh is not associated
with pachymeningitis. There is only one report (42) describ-
ing an idiopathic hypertrophic cranial pachymeningitis of
the cavernous sinus mimicking hypophysitis. These re-
searchers recognized many common features between Ip and
Lh, but they considered than these two pathologies represent
different entities. However, this distinction may not be so
clear, and there are no conclusive histological criteria in the
literature that allow the differential diagnosis of Ip and Lh.
An autoimmune etiology is strongly suspected in Ip as
well as in Lh. The latter is associated in 30% of cases with
other immunological syndromes, such as autoimmune thy-
roiditis, gastric atrophy, or retroperitoneal fibrosis. Cortico-
steroids have been less successful in treatment of Lh; how-
ever, they have been used with lower doses than in Ip (43).
FIG. 11. Transversal T2 spin-echo MRI. Demonstration of hyperin-
tensity involving the white matter in the orbitofrontal area. FIG. 12. Transversal T2 spin-echo MRI. Disappearance of the lesions
is noted.
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We suggest that Lh and Ip could represent two different
manifestations of the same entity, with the former corre-
sponding to a localized Ip of the antehypophysis.
In conclusion, Ip should be considered in the differential
diagnosis of nonadenomatous lesions of the sellar and para-
sellar area. The diagnosis of these lesions is difficult. Histo-
logical, histochemical, and immunohistochemical analysis
are required for diagnosis and to exclude lesions of known
etiology. The distinction between inflammatory and fibrous
types of Ip is crucial, as corticosteroid treatment is efficient
in most cases of inflammatory-type lesions, whereas it may
be ineffective in cases of Ip that harbor extensive fibrosis.
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